Some of the signaling molecules and/or pathways have been identified as constitutively active (by mechanisms involving over-expression of specific molecules or by autocrine/paracrine activation) and therefore are responsible for the aggressive phenotype and metastasis of many cancers, including breast, prostate and colon cancers.